content top

AMD, Hypertension and Potential Cardiovascular Risks with Intravitreal Avastin Injection

http://www.evrs.eu/medias/2006/congress/AMD,-Hypertension-and-Potential-Cardiovascular-Risks-with-Intravitreal-Avastin-Injection.swf Claude Boscher, MD (Paris, France), Maryam Amini, MD (Paris, France), Béryl Cathelineau, MD (Paris, France), Philippe Verdy,  MD (Paris, France), Florence Coscas, MD (Paris, France), Olivier LaPlace, MD (Paris, France), Kathy Perlemuter, MD (Paris, France), Jean Pierre Usdin, MD (Paris,...

Read More

PVD Status as One Strategical Parameter in PDR

Claude Boscher, Beryl Cathelineau, Jean Francois Gautier, Gérard Cathelineau Purpose: Retinal status regarding ischemia and neovascularization is the usual clinical and paraclinical (fluorescein angiography) decisional parameter in PDR; however PVD status (no PVD, partial PVD, total PVD) carries an essential role in the development and course of the disease. Methods: Retrospective series of 600 patients with DR followed and treated between...

Read More

Recurrent Intravitreal Hemorrhage after Endoscopy Assisted Vitrectomy (EAV) for Severe Proliferative Diabetic Retinopathy (PDR)

Claude Boscher, Beryl Cathelineau, P.O. Barale, Raphael S. Amar, Pr Gérard Cathelineau Purpose: Recurrent intravitreal hemorrage after vitrectomy for PDR is reported between 11 and 60% in the literature. Methods: Prospective consecutive non randomized interventional case series of 60 eyes in 47 patients with diabetes 1, and NVC 3 and 4 (DRVS report 3) PDR. Vitrectomy, anterior vitreous base peeling and endophotocoagulation were performed...

Read More
content top